Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

MLTX MoonLake Immunotherapeutics

Watchlist
12.0500.0000.00%
Close  02/03 16:00 ET
12.0500.0000.00%
Post Mkt Price 02/03 16:45 ET
High
12.250
Open
11.970
Turnover
1.02M
Low
11.700
Pre Close
12.050
Volume
84.62K
Market Cap
469.68M
P/E(TTM)
Loss
52wk High
15.190
Shares
38.98M
P/E(Static)
Loss
52wk Low
4.250
Float Cap
62.19M
Bid/Ask %
85.71%
Historical High
15.190
Shs Float
5.16M
Volume Ratio
0.97
Historical Low
4.250
Dividend TTM
--
Div Yield TTM
--
P/B
8.50
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.64%
Amplitude
4.56%
Avg Price
12.042
Lot Size
1
Float Cap
62.19M
Bid/Ask %
85.71%
Historical High
15.190
Shs Float
5.16M
Volume Ratio
0.97
Historical Low
4.250
Dividend TTM
--
P/B
8.50
Dividend LFY
--
Turnover Ratio
1.64%
Amplitude
4.56%
Avg Price
12.042
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.
CEO: Dr. Jorge Santos da Silva
Market: NASDAQ
Listing Date: 10/20/2020
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist